![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, April 23, 2021 12:17:50 PM
Need we say more. Do the DD, please, everyone. NR2F6 may be a very promising component and if Eli Lilly, J&J or someone similar had stepped forward to strike a deal, I'd be all in for the future would not depend on Koos.
But who just licensed it? ONPH, which according to last filing on yahoo did have a bit of revenue back in 2013, but went dark on reporting thereafter, had no cash as of end of 2020, is issuing PRs left and right striking deals with small companies and talking about funding, but with no money, no details and no.... evidence to believe there are anything different from how Koos plays his game. Probably taking fishing trips together on Koos' yacht and came up with the current scheme.
But glad people pushed it from .000 to .06 as I was able to sell my old shares (long and strong - right) above .01 and have some change to invest elsewhere.
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM